FREDUN PHARMACEUTICALS
Back to All Ratios
|
FREDUN PHARMACEUTICALS Last 5 Year EV/EBIT History
[Consolidated]
| Mar2025 | |
|---|---|
| EV/EBIT(x) | 9.58 |
What is the latest EV/EBIT ratio of FREDUN PHARMACEUTICALS ?
| Year | EV/EBIT |
|---|---|
| Mar2025 | 9.58 |
How is EV/EBIT of FREDUN PHARMACEUTICALS Trending?
| Years | EV/EBIT | % Change | |
|---|---|---|---|
| Mar2025 | 9.58 | - | |
Other Financial Ratios of FREDUN PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/EBIT ratio of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹1,306.6 Cr | -0.9% | 6.5% | 210.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,469.0 Cr | -2.8% | -1% | 6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,305.0 Cr | -3.3% | 0.4% | -2.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,014.0 Cr | -3.1% | 2.9% | 36.9% | Stock Analytics | |
| CIPLA | ₹111,388.0 Cr | -2.7% | 5.3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,381.0 Cr | -4.1% | -3.7% | 3.7% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | -0.9% |
6.5% |
210.3% |
| SENSEX | -2.4% |
-3.7% |
-9.2% |
You may also like the below Video Courses